Episodes

Episode 3: Hear this clinical panel share a quick overview of the patient support resources available to help patients with T2D get off to a successful start with this GLP-1 RA treatment option.

Mar 27 2023

Episode 3: Hear this clinical panel share a quick overview of the patient support resources available to help patients with T2D get off to a successful start with this GLP-1 RA treatment option.

This podcast is sponsored by Novo Nordisk, Inc. and is intended for clinicians.

Show More Show Less

15 mins

Failed to add items

Sorry, we are unable to add the item because your shopping basket is already at capacity.

Add to cart failed.

Please try again later

Add to wishlist failed.

Please try again later

Remove from wishlist failed.

Please try again later

Follow podcast failed

Unfollow podcast failed

Listen for free
Episode 2: Listen to the second part of this 3-part series where two clinicians have an in-depth discussion about a head-to-head study comparing two leading oral antidiabetic.

Mar 27 2023

Episode 2: Listen to the second part of this 3-part series where two clinicians have an in-depth discussion about a head-to-head study comparing two leading oral antidiabetic.

This podcast is sponsored by Novo Nordisk, Inc. and is intended for clinicians.

Show More Show Less

15 mins

Failed to add items

Sorry, we are unable to add the item because your shopping basket is already at capacity.

Add to cart failed.

Please try again later

Add to wishlist failed.

Please try again later

Remove from wishlist failed.

Please try again later

Follow podcast failed

Unfollow podcast failed

Listen for free
Episode 1: Hear Davida Kruger, NP and Julio Rosenstock, MD discuss important head-to-head data between a GLP-1 RA and DPP-4 inhibitor as an important consideration when making clinical decisions for patients with T2D.

Mar 27 2023

Episode 1: Hear Davida Kruger, NP and Julio Rosenstock, MD discuss important head-to-head data between a GLP-1 RA and DPP-4 inhibitor as an important consideration when making clinical decisions for patients with T2D.

This podcast is sponsored by Novo Nordisk, Inc. and is intended for clinicians.

Show More Show Less

17 mins

Failed to add items

Sorry, we are unable to add the item because your shopping basket is already at capacity.

Add to cart failed.

Please try again later

Add to wishlist failed.

Please try again later

Remove from wishlist failed.

Please try again later

Follow podcast failed

Unfollow podcast failed

Listen for free

Episodes

Episode 3: Hear this clinical panel share a quick overview of the patient support resources available to help patients with T2D get off to a successful start with this GLP-1 RA treatment option.

Failed to add items

Add to cart failed.

Add to wishlist failed.

Remove from wishlist failed.

Follow podcast failed

Unfollow podcast failed

Episode 2: Listen to the second part of this 3-part series where two clinicians have an in-depth discussion about a head-to-head study comparing two leading oral antidiabetic.

Failed to add items

Add to cart failed.

Add to wishlist failed.

Remove from wishlist failed.

Follow podcast failed

Unfollow podcast failed

Episode 1: Hear Davida Kruger, NP and Julio Rosenstock, MD discuss important head-to-head data between a GLP-1 RA and DPP-4 inhibitor as an important consideration when making clinical decisions for patients with T2D.

Failed to add items

Add to cart failed.

Add to wishlist failed.

Remove from wishlist failed.

Follow podcast failed

Unfollow podcast failed